Literature DB >> 24749647

Influence of the HLA characteristics of Italian patients on donor search outcome in unrelated hematopoietic stem cell transplantation.

M Testi1, M Andreani, F Locatelli, W Arcese, M Troiano, M Battarra, J Gaziev, G Lucarelli.   

Abstract

The information regarding the probability of finding a matched unrelated donor (MUD) within a relatively short time is crucial for the success of hematopoietic stem cell transplantation (HSCT), particularly in patients with malignancies. In this study, we retrospectively analyzed 315 Italian patients who started a search for a MUD, in order to assess the distribution of human leukocyte antigen (HLA) alleles and haplotypes in this population of patients and to evaluate the probability of finding a donor. Comparing two groups of patients based on whether or not a 10/10 HLA-matched donor was available, we found that patients who had a fully-matched MUD possessed at least one frequent haplotype more often than the others (45.6% vs 14.3%; P = 0.000003). In addition, analysis of data pertaining to the HLA class I alleles distribution showed that, in the first group of patients, less common alleles were under-represented (20.2% vs 40.0%; P = 0.006). Therefore, the presence of less frequent alleles represents a negative factor for the search for a potential compatible donor being successful, whereas the presence of one frequent haplotype represents a positive predictive factor. Antigenic differences between patient and donor observed at C and DQB1 loci, were mostly represented by particular B/C or DRB1/DQB1 allelic associations. Thus, having a particular B or DRB1 allele, linked to multiple C or DQB1 alleles, respectively, might be considered to be associated with a lower probability of a successful search. Taken together, these data may help determine in advance the probability of finding a suitable unrelated donor for an Italian patient.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  hematopoietic stem cell transplantation; human leukocyte antigen; matched unrelated donor search

Mesh:

Substances:

Year:  2014        PMID: 24749647     DOI: 10.1111/tan.12355

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  5 in total

1.  The increase of the global donor inventory is of limited benefit to patients of non-Northwestern European descent.

Authors:  Suzanna M van Walraven; Anneke Brand; Jack N A Bakker; Martin B A Heemskerk; Suzan Nillesen; Marc B Bierings; Laura B Bungener; Bouke G Hepkema; Arjan Lankester; Arnold van der Meer; Kees Sintnicolaas; Judith A E Somers; Eric Spierings; Marcel G J Tilanus; Christien E M Voorter; Jan J Cornelissen; Machteld Oudshoorn
Journal:  Haematologica       Date:  2016-08-25       Impact factor: 9.941

2.  HLA-C*18:01: A Rare Allele in the European Caucasian Population Coinciding with Difficult-to-Treat Plaque Psoriasis.

Authors:  M Galluzzo; M Andreani; M Testi; S Chimenti; M Talamonti
Journal:  Mol Diagn Ther       Date:  2016-06       Impact factor: 4.074

Review 3.  How to select the best available related or unrelated donor of hematopoietic stem cells?

Authors:  Jean-Marie Tiercy
Journal:  Haematologica       Date:  2016-05-31       Impact factor: 9.941

4.  High-resolution HLA phased haplotype frequencies to predict the success of unrelated donor searches and clinical outcome following hematopoietic stem cell transplantation.

Authors:  Stéphane Buhler; Helen Baldomero; Sylvie Ferrari-Lacraz; José Manuel Nunes; Alicia Sanchez-Mazas; Stravroula Massouridi-Levrat; Dominik Heim; Jörg Halter; Gayathri Nair; Yves Chalandon; Urs Schanz; Tayfun Güngör; Grazia Nicoloso; Jean-Marie Tiercy; Jakob Passweg; Jean Villard
Journal:  Bone Marrow Transplant       Date:  2019-04-05       Impact factor: 5.483

5.  HLA allele frequencies and susceptibility to COVID-19 in a group of 99 Italian patients.

Authors:  Antonio Novelli; Marco Andreani; Michela Biancolella; Laura Liberatoscioli; Chiara Passarelli; Vito Luigi Colona; Paola Rogliani; Francesca Leonardis; Andrea Campana; Rita Carsetti; Massimo Andreoni; Sergio Bernardini; Giuseppe Novelli; Franco Locatelli
Journal:  HLA       Date:  2020-09-03       Impact factor: 8.762

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.